Atellica Unveils Cutting-Edge Integrated Diagnostic Analyzer with Mahajan Imaging & Labs

Atellica has launched the new Atellica CI Analyzer at Mahajan Imaging & Labs, revolutionizing patient care with faster and more accurate diagnostics. This FDA-approved device offers extensive diagnostic capabilities, enhancing predictive care and ensuring precise results, significantly improving overall patient well-being and diagnostic workflows.

Atellica, a world leader in medical diagnostics, has introduced the Atellica CI Analyzer at Mahajan Imaging & Labs. This state-of-the-art device aims to enhance patient care by delivering faster and more accurate diagnostic results, addressing the evolving demands of modern healthcare.

Dr. Harsh Mahajan, Founder and Chief Radiologist at Mahajan Imaging & Labs, emphasized the significance of this innovation. He noted that the Atellica CI Analyzer plays a crucial role in decision-making for various medical conditions. 'Being the first to implement this analyzer is a milestone, strengthening our path in integrated diagnostics,' he said.

The device, crucial in the fight against liver disease, accurately predicts liver conditions non-invasively. Experts highlight the analyzer's ability to offer rapid, precise results, improving both diagnostics and patient experience. The compact analyzer can handle over 200 parameters, vital for pediatric and critical care, processing critical tests in just 14 minutes, demonstrating a leap in diagnostic speed and reliability.

Ranabir Sinha of Siemens Healthineers underscored the shared vision of utilizing advanced technology to bolster healthcare professionals' capabilities. Lab Director Dr. Shelly Mahajan noted the rigorous validation over five months, adding that the analyzer ensures quick turnaround times and adheres to environmental goals. This breakthrough technology secured FDA approval, affirming its safety, effectiveness, and reliability.

(With inputs from agencies.)